Stock Market Today, April 28: Erasca Plunges After Patient Death in Early Cancer Drug Trial
28/4 23:19
Erasca (NASDAQ:ERAS), a developer of therapies for RAS/MAPK pathway-driven cancers, closed at $9.90, down 48% on Tuesday. Shares fell after the company disclosed a patient death from pneumonitis in its ERAS-0015 trial. Investors are watching for clearer safety data. Trading volum...